Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04998617 · ClinicalTrials.gov registry record · NA
Effects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis
A NA study of Halitosis, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04998617: Completed NA study of Halitosis, sponsored by University of North Carolina, Chapel Hill.
NCT04998617 is a NA study of Halitosis that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants, below the 49-participant average among 3 other Halitosis trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04998617, a NA study of Halitosis, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: To investigate the short-term clinical effect of curcumin-containing toothpaste on halitosis as compared to placebo and to assess potential shifts in the composition of dental biofilm associated with the use of curcumin-containing toothpaste Participants: This clinical study will 30 adult participants under prophylactic or periodontal maintenance protocol. Procedures (methods): Participants will be included and throughout the protocol will not allow the use any other oral hygiene products except standard manual toothbrush and study toothpaste (either test -curcumin-containing or placebo). Additionally participants will be instructed to odiferous foods such as onions, garlic and spices. At each of the three examination sessions, Plaque Index (six sites, O'Leary) and volatile sulphur compounds (VSC) will be measured.
Primary Outcome
Volatile Sulphur Compounds (VSC) values for all subjects will be recorded. F-tests will be used to compare the curcumin group with the placebo group at each timepoint. P-values less than 0.05 will be considered statistically significant. Analyses will be performed using SAS Version 9.4 (SAS Institute, Cary NC).
Conditions Studied
Interventions
- OTHER Toothpaste with curcumin
- OTHER Toothpaste without curcumin
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-24 |
| Est. Completion | 2023-05-05 |
| Phase | NA |
What the finished NCT04998617 record still lists
NCT04998617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 49-participant average among 3 other Halitosis trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Halitosis appearing as the primary indexed condition, and to 2 interventions - of which Toothpaste with curcumin is the first listed.
NCT04998617 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04998617 about?
NCT04998617 is a clinical study titled "Effects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis". Purpose: To investigate the short-term clinical effect of curcumin-containing toothpaste on halitosis as compared to placebo and to assess potential shifts in the composition of dental biofilm associated with the use of curcumin-containing toothpaste Participants: This clinical study will 30 adult ...
What is the current status of trial NCT04998617?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-05-24. Estimated completion is 2023-05-05.
What conditions does trial NCT04998617 study?
This clinical trial studies the following conditions: Halitosis.
What interventions are being tested in trial NCT04998617?
The interventions under investigation include: Toothpaste with curcumin (OTHER), Toothpaste without curcumin (OTHER).
Who is sponsoring clinical trial NCT04998617?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04998617 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Halitosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Whitening Agent With Emulsion Gel in Saliva and Halitosis
ACTIVE NOT RECRUITING · NA
-
A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With Gingivitis
COMPLETED · NA
-
Effectiveness of Aquamin® in Mitigating Halitosis
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI